• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

突尼斯北部宫颈癌发病率的趋势及预测(1994 - 2040年)

Trends and projections in cervical cancer incidence in northern Tunisia (1994-2040).

作者信息

Khiari Hyem, Abdelfatteh Yasmine Ben, Mahjoub Najet, Mekni Karima, Chadli Ashraf, Aissi Wafa, Hsairi Mohamed

机构信息

Department of Epidemiology and Biostatistics, Salah Azaiz Institute, Faculty of medicine of Tunis, Tunis, Tunisia.

Department of Oncology, Jendouba Hospital, Jendouba, Tunisia.

出版信息

BMC Cancer. 2025 Apr 21;25(1):739. doi: 10.1186/s12885-025-13626-x.

DOI:10.1186/s12885-025-13626-x
PMID:40259222
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12010527/
Abstract

BACKGROUND

Cervical cancer (CC) is a major public health problem; it is the fourth leading cause of cancer in women worldwide. The present study aimed to analyze trends and projections in incidence of CC in northern Tunisia during the period 1994-2040.

METHODS

Crude and Age standardized CC incidence were calculated. Joinpoint software was used to dress trends in incidence. Projections were assessed using the age period cohort model.

RESULTS

This study revealed 3092 cases of CC during the period 1994-2018 in northern Tunisia, representing an annual number of 129. The mean age at diagnostic was of 56 ± 12.9 years with extremes ranging from 19 to 88 years old. The crude and standardized incidence rates were respectively of 4.9/100,000 and 5.2 /100,000 women year in 2018. A downward trend in the age standardized incidence rate of CC was confirmed in northern Tunisia from 6.6 in 1994 to 4.7 in 2018 with an Annual Percentage Change (APC) of -1.8%, Confidence interval (CI) at 95% of [-2.9; -0.6]; (p = 10). Trends analysis have also described three periods: the first one from 1994 to 1998 with a stable trend. The second period was from 1998 to 2006 with a significant decreasing trend with an APC of -7.2%, CI at 95% of [-13.0; -1.0]; (p = 0.02) and the third period was from 2006 to 2014 with a non-significant APC. According to projections, the number of new cases would be of 2017 in 2040 with an age standardized rate between 3.8 and 5.8/100,000 women year.

CONCLUSION

Results of this study underscore the need for the application of CC control program in Tunisia, with efforts focused on improving access to and participation in screening programs, HPV vaccination for females and ensuring timely access to effective treatment services.

摘要

背景

宫颈癌是一个重大的公共卫生问题,是全球女性癌症的第四大主要病因。本研究旨在分析1994年至2040年期间突尼斯北部宫颈癌发病率的趋势和预测情况。

方法

计算了宫颈癌的粗发病率和年龄标准化发病率。使用Joinpoint软件梳理发病率趋势。采用年龄-时期-队列模型评估预测情况。

结果

本研究揭示了1994年至2018年期间突尼斯北部有3092例宫颈癌病例,年均病例数为129例。诊断时的平均年龄为56±12.9岁,年龄范围从19岁至88岁。2018年的粗发病率和标准化发病率分别为每10万女性每年4.9例和5.2例。突尼斯北部宫颈癌年龄标准化发病率呈下降趋势,从1994年的6.6降至2018年的4.7,年度百分比变化(APC)为-1.8%,95%置信区间(CI)为[-2.9;-0.6];(p = 0.01)。趋势分析还描述了三个时期:第一个时期为1994年至1998年,呈稳定趋势。第二个时期为1998年至2006年,呈显著下降趋势,APC为-7.2%,95%CI为[-13.0;-1.0];(p = 0.02),第三个时期为2006年至2014年,APC不显著。根据预测,到2040年新发病例数将为2017例,年龄标准化发病率在每10万女性每年3.8至5.8例之间。

结论

本研究结果强调了在突尼斯实施宫颈癌控制项目的必要性,努力重点在于改善筛查项目的可及性和参与度、为女性接种人乳头瘤病毒疫苗以及确保及时获得有效的治疗服务。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b03/12010527/a655b7f95447/12885_2025_13626_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b03/12010527/fde94aead756/12885_2025_13626_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b03/12010527/9160cfbadc7d/12885_2025_13626_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b03/12010527/fb25ecfe6dc5/12885_2025_13626_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b03/12010527/fff8fd9b5dfd/12885_2025_13626_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b03/12010527/f14deaed6339/12885_2025_13626_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b03/12010527/a655b7f95447/12885_2025_13626_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b03/12010527/fde94aead756/12885_2025_13626_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b03/12010527/9160cfbadc7d/12885_2025_13626_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b03/12010527/fb25ecfe6dc5/12885_2025_13626_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b03/12010527/fff8fd9b5dfd/12885_2025_13626_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b03/12010527/f14deaed6339/12885_2025_13626_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b03/12010527/a655b7f95447/12885_2025_13626_Fig6_HTML.jpg

相似文献

1
Trends and projections in cervical cancer incidence in northern Tunisia (1994-2040).突尼斯北部宫颈癌发病率的趋势及预测(1994 - 2040年)
BMC Cancer. 2025 Apr 21;25(1):739. doi: 10.1186/s12885-025-13626-x.
2
HPV types and variants among cervical cancer tumors in three regions of Tunisia.突尼斯三个地区宫颈癌肿瘤中的 HPV 类型和变体。
J Med Virol. 2011 Apr;83(4):651-7. doi: 10.1002/jmv.22011.
3
Cervical adenocarcinoma and squamous cell carcinoma incidence trends among Tunisian women.突尼斯女性宫颈癌和鳞状细胞癌的发病率趋势
Asian Pac J Cancer Prev. 2010;11(3):777-80.
4
Type-Specific Human Papillomavirus Distribution in Invasive Squamous Cervical Carcinomas in Tunisia and Vaccine Impact.突尼斯浸润性宫颈鳞状细胞癌中特定类型人乳头瘤病毒的分布及疫苗影响
Asian Pac J Cancer Prev. 2015;16(15):6769-72. doi: 10.7314/apjcp.2015.16.15.6769.
5
Estimated Cancer Incidence in Northern Tunisia in 2023: Northern Tunisia Cancer Registry.2023年突尼斯北部癌症发病率预估:突尼斯北部癌症登记处
Asian Pac J Cancer Prev. 2024 Dec 1;25(12):4359-4369. doi: 10.31557/APJCP.2024.25.12.4359.
6
Epidemiology and disease burden of tuberculosis in south of Tunisia over a 22-year period: Current trends and future projections.突尼斯南部地区 22 年间结核病的流行病学和疾病负担:当前趋势和未来预测。
PLoS One. 2019 Jul 24;14(7):e0212853. doi: 10.1371/journal.pone.0212853. eCollection 2019.
7
Colorectal Cancer Incidence Trend and Projections in Tunisia (1994 - 2024).突尼斯的结直肠癌发病率趋势及预测(1994 - 2024年)。
Asian Pac J Cancer Prev. 2017 Oct 26;18(10):2733-2739. doi: 10.22034/APJCP.2017.18.10.2733.
8
Increasing risk of uterine cervical cancer among young Japanese women: Comparison of incidence trends in Japan, South Korea and Japanese-Americans between 1985 and 2012.日本、韩国和日本裔美国人 1985 年至 2012 年期间宫颈癌发病率趋势比较:年轻日本女性的患病风险上升。
Int J Cancer. 2019 May 1;144(9):2144-2152. doi: 10.1002/ijc.32014. Epub 2018 Dec 18.
9
Global, regional, and national burden of breast, cervical, uterine, and ovarian cancer and their risk factors among women from 1990 to 2021, and projections to 2050: findings from the global burden of disease study 2021.1990年至2021年全球、区域和国家层面女性乳腺癌、宫颈癌、子宫癌和卵巢癌负担及其风险因素,以及到2050年的预测:全球疾病负担研究2021的结果
BMC Cancer. 2025 Feb 24;25(1):330. doi: 10.1186/s12885-025-13741-9.
10
Temporal Changes in Incidence Rates of the Most Common Gynecological Cancers in the Female Population in Central Serbia.塞尔维亚中部女性人群中最常见妇科癌症发病率的时间变化。
Medicina (Kaunas). 2022 Feb 17;58(2):306. doi: 10.3390/medicina58020306.

本文引用的文献

1
Estimated Cancer Incidence in Northern Tunisia in 2023: Northern Tunisia Cancer Registry.2023年突尼斯北部癌症发病率预估:突尼斯北部癌症登记处
Asian Pac J Cancer Prev. 2024 Dec 1;25(12):4359-4369. doi: 10.31557/APJCP.2024.25.12.4359.
2
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.2022 年全球癌症统计数据:全球 185 个国家和地区 36 种癌症的发病率和死亡率全球估计数。
CA Cancer J Clin. 2024 May-Jun;74(3):229-263. doi: 10.3322/caac.21834. Epub 2024 Apr 4.
3
Global Cervical Cancer Incidence by Histological Subtype and Implications for Screening Methods.
按组织学亚型划分的全球宫颈癌发病率及其对筛查方法的影响
J Epidemiol Glob Health. 2024 Mar;14(1):94-101. doi: 10.1007/s44197-023-00172-7. Epub 2024 Jan 3.
4
Cervical Cancer Screening Recommendations: Now and for the Future.宫颈癌筛查建议:现状与未来
Healthcare (Basel). 2023 Aug 11;11(16):2273. doi: 10.3390/healthcare11162273.
5
Quality indicators: completeness, validity and timeliness of cancer registry data contributing to the European Cancer Information System.质量指标:为欧洲癌症信息系统提供数据的癌症登记数据的完整性、有效性和及时性。
Front Oncol. 2023 Jul 28;13:1219128. doi: 10.3389/fonc.2023.1219128. eCollection 2023.
6
Cancer incidence and mortality trends in Asia based on regions and human development index levels: an analyses from GLOBOCAN 2020.亚洲地区基于区域和人类发展指数水平的癌症发病和死亡趋势:基于 GLOBOCAN 2020 的分析。
Curr Med Res Opin. 2023 Aug;39(8):1127-1137. doi: 10.1080/03007995.2023.2231761. Epub 2023 Jul 17.
7
HPV and Cervical Cancer: A Review of Epidemiology and Screening Uptake in the UK.人乳头瘤病毒与宫颈癌:英国流行病学及筛查情况综述
Pathogens. 2023 Feb 11;12(2):298. doi: 10.3390/pathogens12020298.
8
Distribution of high-risk human papillomavirus in women with ASC-US or LSIL in Tunisian women: Place of HPV testing for women triage in Tunisia.在突尼斯女性中,ASC-US 或 LSIL 女性中高危型人乳头瘤病毒的分布:HPV 检测在突尼斯女性分诊中的地位。
Diagn Microbiol Infect Dis. 2023 Mar;105(3):115859. doi: 10.1016/j.diagmicrobio.2022.115859. Epub 2022 Nov 12.
9
Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative.2020 年全球宫颈癌发病率和死亡率估计:世卫组织全球消除宫颈癌倡议的基线分析。
Lancet Glob Health. 2023 Feb;11(2):e197-e206. doi: 10.1016/S2214-109X(22)00501-0. Epub 2022 Dec 14.
10
Global and regional estimates of orphans attributed to maternal cancer mortality in 2020.2020 年归因于母亲癌症死亡的孤儿的全球和区域估计数。
Nat Med. 2022 Dec;28(12):2563-2572. doi: 10.1038/s41591-022-02109-2. Epub 2022 Nov 20.